Table 2 Normal values of myocardial ECV at different studies
From: T1 mapping: characterisation of myocardial interstitial space
Field strength | Scanner | Contrast | Technique | Dose (mmol/kg) | T1 mapping sequence | ECV (%) | |
|---|---|---|---|---|---|---|---|
Broberg et al. [60] 2010 | 1.5 T/3 T | Achieva/Intera, Philips | Gadodiamida | Only bolus | 0.15 | Look-Locker | 24.8 |
Schelbert et al. [56] 2011 | 1.5 T | Espree, Siemens | Gadoteridol | Only bolus | 0.2 | MOLLI | 24.1 |
Lee et al. [58] 2011 | 3 T | Verio, Siemens | Gadopentetate Dimeglumine | Only bolus | 0.15 | MOLLI | 26.7 |
Kellman et al. [61] 2012 | 1.5 T | Avanto/Espree, Siemens | Gd-DTPA | Only bolus | 0.15 | MOLLI | 25.4 |
Sado et al. [85] 2012 | 1.5 T | Avanto, Siemens | Gadoterate Meglumine | Bolus + infusion | 0.1 + 0.002/mina | FLASH IR | 25.3 |
Salerno et al. [62] 2013 | 1.5 T | Avanto, Siemens | Gd-DTPA | Bolus + infusion | 0.1 + 0.001/minb | MOLLI | 28.5 |
Liu et al. [86] 2013 | 1.5 T | Avanto/Espree, Siemens | Gadopentetate Dimeglumine | Only bolus | 0.15 | MOLLI | 26.9 |